Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2025-12-26 @ 1:46 AM
Study NCT ID:
NCT00833833
Status:
COMPLETED
Last Update Posted:
2016-04-27
First Post:
2009-01-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
Sponsor:
Celgene Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CC-4047-MM-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None